NCT05110183
Opto-electrical Cochlear Implants
Enrolling by Invitation
NAAges 18–89InterventionalDevice feasibilityNorthwestern UniversityInvestigator-initiated
~30 participants
Updated 2026-05-06 on ClinicalTrials.gov
What's tested:electrical stimulationoptical stimulationcombined optical and electrical stimulation
At a glance
Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Compound Action Potential (CAP)
Measured over 30 minutes
Conditions
Where it's being run
2 sites across 2 statesFlorida1
Missouri1
Study leadership
- Claus-Peter Richter, MD, PhD · PRINCIPAL_INVESTIGATOR · Northwestern University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Exclusion
adults unable to consent.
individuals who are not yet adults (infants, children, teenagers).
pregnant women.
prisoners.
vulnerable populations
What this trial measures
- Compound Action Potential (CAP)30 minutes
Compound action potentials (CAPs) of the auditory nerve in response to electrical stimulation, optical stimulation, and combined optical and electrical stimulation will be recorded. Electrical stimulation alone is used to determine baseline cochlear function. Optical stimulation alone will then be used to determine a similar baseline for optical stimulation and test parameters such as optical pulse rate, pulse duration and radiant exposure.